BIO.News Newsletter

A new study confirms that climate change is making infectious disease worse—and we’re seeing this play out in real time right here in the U.S. Meanwhile, the FDA’s EUA yesterday will make more monkeypox vaccine doses available. (761 words, 3 minutes, 48 seconds)

Pfizer will acquire sickle cell pioneer Global Blood Therapeutics, the sickle cell pioneer led by BIO Vice Chair Dr. Ted Love. We have the details, plus a look at how climate change is playing a role in the increase in Lyme disease. (859 words, 4 minutes, 17 seconds)

The Senate passed innovation-killing drug price controls yesterday—here’s what you need to know about the legislation and what’s expected to happen next. Plus, with drought ravaging the U.S., we look at biotech solutions and the policy needed to deploy them. (823 words, 4 minutes, 6 seconds)

It’s not too late to take action on drug price controls—we tell you why (and how). Plus, the busy summer continues with the Biden administration declaring monkeypox a Public Health Emergency and the FDA releasing much-needed educational materials on GMOs. (659 words, 3 minutes, 17 seconds)

A briefing yesterday explained how proposed drug price controls will rip apart America’s biotech ecosystem—plus, Gevo announces a deal with Alaska Airlines, the latest in a spate of deals that will advance sustainable aviation fuel. (721 words, 3 minutes, 36 seconds)

With Senate Democrats scrambling to pass drug price controls before the recess, we look at the experiences of the EU and Japan with price controls and the impact on innovation. ICYMI, monkeypox cases are rising—we look at the current state and what it tells us about future preparedness. (829 words, 4 minutes, 8 seconds)

Drug price controls would not only kill future cures—but would also harm the economy, several new studies say. Plus, the pandemic might have curbed greenhouse gas emissions (for a time), but it led to a resurgence of the plastic problem. Enter biotech, which is developing sustainable alternatives to single-use plastic. (753 words, 3 minutes, 45 seconds)

A new week, a new month—and the last week the Senate’s in session before the August recess. We’ll be keeping an eye on what happens with the “slimmed down” Build Back Better, which includes anti-science drug price controls. Meanwhile, we’re worried about the heat—but we should also be worried about soil, says the UN. (651 words, 3 minutes, 15 seconds)

With drug price controls under consideration in the Senate, new analysis shows how they would devastate drug development and new treatments. On World Hepatitis Day, we look at why this preventable, treatable virus is still a threat. (740 words, 3 minutes, 42 seconds) P.S. The BIO Impact Agriculture & Environment conference is right around the corner. Be sure to register today.

Ending the week with what USTR nominee Doug McKalip said about agricultural biotech trade with Mexico and Korea, plus a new report that shows the dire need to invest in public health infrastructure and preparedness. (783 words, 3 minutes, 54 seconds)